Form 4 for PACS PACS Group, Inc.
Accepted 2026-07-06 18:50:12 ET · period of report 2026-07-01 · accession 0002014361-26-000022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-06 18:50 | 2026-07-01 | PACS | Hancock Mark | Dir, 10% | A - Grant | $0.00 | +4,287 | 54.11M | +0.0% | $0 |
| MT | 2026-07-06 18:50 | 2026-07-01+ | PACS | Hancock Mark | Dir, 10% | S - Sale | $45.30 | -161.1K | 53.95M | -0.3% | -$7.30M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-01 | A | A | 4,287 | $0.00 | 54,106,884 | D | — | — | (F1) Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer. |
| 2 | Common | Common Stock | 2026-07-01 | S | D | 6,080 | $45.02 | 54,100,804 | D | — | — | (F2) The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. (F3) The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.075 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2026-07-02 | S | D | 12,825 | $45.01 | 54,087,979 | D | — | — | (F2) The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. (F4) The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.115 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2026-07-06 | S | D | 142,163 | $45.33 | 53,945,816 | D | — | — | (F2) The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. (F5) The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.88 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |